Osaic Holdings
RETA

Osaic Holdings’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Osaic Holdings’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,406
Closed -$551K – 7604
2023
Q2 		$551K Sell
5,406
-2,863
-35% -$271K ﹤0.01% 3063
2023
Q1 		$752K Buy
8,269
+6,717
+433% +$394K ﹤0.01% 2751
2022
Q4 		$58K Buy
1,552
+1,524
+5,443% +$52.4K ﹤0.01% 4827
2022
Q3 		$0 Sell
28
-11
-28% -$305 ﹤0.01% 7634
2022
Q2 		$0 Sell
39
-204
-84% -$6.09K ﹤0.01% 7712
2022
Q1 		$7K Buy
243
+18
+8% +$534 ﹤0.01% 6361
2021
Q4 		$6K Sell
225
-1,115
-83% -$86.3K ﹤0.01% 6582
2021
Q3 		$138K Sell
1,340
-346
-21% -$40.6K ﹤0.01% 4250
2021
Q2 		$240K Sell
1,686
-553
-25% -$62.4K ﹤0.01% 3711
2021
Q1 		$223K Sell
2,239
-237
-10% -$27.6K ﹤0.01% 3640
2020
Q4 		$306K Buy
2,476
+588
+31% +$77.3K ﹤0.01% 3106
2020
Q3 		$184K Buy
1,888
+1,725
+1,058% +$216K ﹤0.01% 3331
2020
Q2 		$26K Buy
163
+158
+3,160% +$24K ﹤0.01% 4646
2020
Q1 		$0 Buy
+5
New +$965 ﹤0.01% 6241

Other funds holding RETA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings's RETA Position: Q3 2023 in Review

Osaic Holdings sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 5,406 shares — an estimated $551K sold.

Osaic Holdings first reported a position in RETA in Q1 2020 and held it in 14 quarters. The position peaked at $752K in Q1 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

  • Osaic Holdings reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Osaic Holdings sold 5,406 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $551K.
  • Osaic Holdings first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2020 and held it in 14 quarters.
  • Osaic Holdings's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $752K in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.